Position in AZN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$372,769,659
New position
Shares Held
1,890,121
first reported quarter
Ownership
0.122%
of shares outstanding
% of Portfolio
4.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LGT Group Foundation holds $1,040,407,974 across 8 Drug Manufacturers - General names. AZN ranks #1 (35.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
1,890,121 | $372,769,659 | |
| 2 | LLY |
ELI LILLY & Co
|
399,693 | $367,625,628 | |
| 3 | JNJ |
Johnson & Johnson
|
497,989 | $121,728,428 | |
| 4 | ABBV |
AbbVie Inc.
|
413,651 | $89,964,953 | |
| 5 | PFE |
Pfizer Inc
|
2,206,233 | $61,951,021 | |
| 6 | MRK |
Merck & Co., Inc.
|
194,925 | $23,447,526 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
19,824 | $1,202,324 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $372,769,659 | 1,890,121 | Shares | Defined | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||